Nelfinavir - major trial results at retroviruses conference.
D019380:Anti-HIV Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage* / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D019888:Nelfinavir; D018119:Stavudine / Q000627:therapeutic use; D013451:Sulfonic Acids / Q000008:administration & dosage* / Q000627:therapeutic use; D019562:Viral Load; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D013451:Sulfonic Acids; D019259:Lamivudine; D015215:Zidovudine; D018119:Stavudine; D019888:Nelfinavir